A federal grand jury Dec. 15 returned an indictment against the head of a California-based medical device company charging him with defrauding investors by making false and misleading statements about the purported development of a test for COVID-19. According to federal prosecutors, the scheme — which allegedly included press releases that falsely reported progress toward sec... Read More